BioCentury
ARTICLE | Clinical News

Recombinant coagulation Factor XIII: Phase III started

November 10, 2008 8:00 AM UTC

In August, Novo began an open-label, international Phase III trial of intravenous rh FXIII in 40 patients. Novo licensed the product from ZymoGenetics in 2004 (see BioCentury, Oct. 11, 2004). ...